Clementia

Pharma

After much trial and error, Ipsen scores FDA nod for Sohonos

After traveling a long road full of potholes, Ipsen has reached its destination, gaining FDA approval for Sohonos to treat an ultra-rare bone disease.

Kevin Dunleavy Aug 17, 2023 8:28am

2017’s Fiercest Women in Life Sciences

Dec 5, 2017 9:00am